About

About Gel Coat Biomaterials, Inc. Gel Coat Biomaterials Inc. is a top leading company in enzyme stabilization, founded on the Amoeba Hydrogel Technology (AHT) discovered and developed by Professor Madoka Takai at the University of Tokyo. AHT enhances the stability of bio-products such as enzymes and biopharmaceuticals for wide applications. First, AHT stabilizes and immobilizes enzymes used in API (Active Pharmaceutical Ingredient) manufacturing, dramatically improving the efficiency of the API production process. Second, AHT suppresses the degradation of biopharmaceuticals and enzyme-based drugs within the body for improving pharmacokinetics (PK). Third, novel enzymes for special applications are stabilized and/or immobilized. Forth, biocompatible bioelectric power generation devices for innovative implantable medical devices is developed based on AHT.